Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01369966 · ClinicalTrials.gov registry record

Brain Circuits in Schizophrenia and Smoking

A clinical trial, sponsored by National Institute on Drug Abuse (NIDA).

Completed
Registry status
42
Enrollment target

NCT01369966 is a clinical trial that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 42 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01369966 has completed, sponsored by National Institute on Drug Abuse (NIDA).

COMPLETED
Registry status
42 participants
Enrollment target

Study Summary

Background: \- Smoking is associated with serious health risks. People who have mental illness are more likely to smoke. Researchers are studying the brain circuits linked with smoking and nicotine craving. This study will look at whether a specific brain circuit can explain the high rate of smoking in people with schizophrenia. Objectives: \- To study brain activity in smokers and nonsmokers with and without schizophrenia, as well as their family members. Eligibility: * Current smokers (at least 100 cigarettes in the past year) and nonsmokers between 18 and 62 years of age in one of the following groups: * Have been diagnosed with schizophrenia. * Family members of those with schizophrenia. * Healthy adults with no history of severe mental illness or brain trauma. * Family members of the healthy adults. Design: * People in the study will be screened with a physical exam, medical history, questionnaires, and blood tests. * They will have up to three visits: the screening visit and two study visits (each given 1 year apart). * At the first study visit, those taking part will be trained in the tests they will do during the magnetic resonance imaging (MRI) scan. Then they will have the MRI scan. * After the first study visit, current smokers will receive phone calls from the study researchers every other month for 1 year. They will be asked about their smoking habits. * At the second study visit, current smokers and some nonsmokers will have another MRI scan and the same tests as before. * Current smokers will receive a final phone call 1 year after the second study visit. They will be asked to give information about their smoking habits.

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2011-05-16
Est. Completion 2014-12-24

What the Registry Record Tells You About NCT01369966

The ClinicalTrials.gov registry entry for NCT01369966 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01369966 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01369966 about?

NCT01369966 is a clinical study titled "Brain Circuits in Schizophrenia and Smoking". Background: \- Smoking is associated with serious health risks. People who have mental illness are more likely to smoke. Researchers are studying the brain circuits linked with smoking and nicotine craving. This study will look at whether a specific brain circuit can explain the high rate of smokin...

What is the current status of trial NCT01369966?

This trial is currently completed. The enrollment target is 42 participants. The study started on 2011-05-16. Estimated completion is 2014-12-24.

Who is sponsoring clinical trial NCT01369966?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.